The Scientist

» virology, culture and disease/medicine

Most Recent

image: Hot Off the Presses

Hot Off the Presses

By | June 1, 2016

Beyond Biocentrism, The Sting of the Wild, The Birth of Anthropocene, and Ordinarily Well

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | June 1, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Start Making Sense

Start Making Sense

By | June 1, 2016

Scientific progress is only achieved when humans' innate sense of understanding is validated by objective reality.

6 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

2 Comments

image: Opinion: The Zika Effect

Opinion: The Zika Effect

By | May 27, 2016

Three reasons why virologists are flocking to study this emerging virus

3 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Genetic Connections Among Human Traits

Genetic Connections Among Human Traits

By | May 16, 2016

A study identifies genetic variants that are linked to multiple phenotypes.

0 Comments

image: Sea Star Comeback?

Sea Star Comeback?

By | May 9, 2016

Hordes of baby sea stars on the Pacific coast survived the summer and winter of 2015—promising news about populations that have been devastated by a wasting disease.

0 Comments

image: New Zika Diagnostic

New Zika Diagnostic

By | May 9, 2016

A paper-based RNA test may offer a low-cost method for detecting the virus in the field.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech